Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice

Journal of Clinical Investigation

Volumn 120, Issue 5, 2010, Pages 1429-1440

  Olivera, Ana ^a   Eisner, Christoph ^b   Kitamura, Yoshiaki ^a   Dillahunt, Sandra ^a   Allende, Laura ^b   Tuymetova, Galina ^b   Watford, Wendy ^a   Meylan, Francoise ^a   Diesner, Susanne C ^a   Li, Ngli ^b   Schnermann, Jurgen ^b   Proia, Richard L ^b   Rivera, Juan ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; POLYINOSINIC POLYCYTIDYLIC ACID; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2 AGONIST; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CELL TRANSFER; EXPERIMENTAL MODEL; HEMATOPOIETIC CELL; HISTAMINE BLOOD LEVEL; HYPOTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ANAPHYLAXIS; ANIMALS; BONE MARROW TRANSPLANTATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLOMERULAR FILTRATION RATE; HEMATOPOIETIC STEM CELLS; HISTAMINE; KIDNEY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PERMEABILITY; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID;

EID: 77951817430     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40659     Document Type: Article

References (61)

1. Felix SB, Baumann G, Berdel WE. Systemic anaphylaxis-- separation of cardiac reactions from respiratory and peripheral vascular events. Res Exp Med (Berl). 1990;190(4):239-252. (Pubitemid 20240570)
2. Galli SJ. Chair's introduction. Anaphylaxis. Novartis Found Symp. 2004;257:1-5.
3. Simons FE. 9. Anaphylaxis. J Allergy Clin Immunol. 2008;121(2 Suppl):S402-S407; quiz S420.
4. Blank U, Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 2004; 25(5):266-273. (Pubitemid 38501673)
5. El-Shanawany T, Williams PE, Jolles S. Clinical immunology review series: an approach to the patient with anaphylaxis. Clin Exp Immunol. 2008; 153(1):1-9. (Pubitemid 351809348)
6. Rivera J, Proia RL, Olivera A. The alliance of sphingosine- 1-phosphate and its receptors in immunity. Nat Rev Immunol. 2008;8(10):753-763.
7. Ammit AJ, et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001;15(7):1212-1214.
8. Jolly P, Rosenfeldt H, Milstien S, Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol Immunol. 2002;38(16-18):1239-1251.
9. Idzko M, et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest. 2006;116(11):2935-2944. (Pubitemid 44684478)
10. Sumi T, et al. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice. Cell Biol Int. 2009;33(4):534-541.
11. Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fεc receptor I triggering. J Exp Med. 1999;190(1):1-8. (Pubitemid 29330118)
12. Camerer E, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009; 119(7):1871-1879.
13. Olivera A, et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem. 2006;2 81(5):2515-2525. (Pubitemid 43845711)
14. Choi OH, Kim JH, Kinet JP. Calcium mobilization via sphingosine kinase in signalling by the FcεRI antigen receptor. Nature. 1996;380(6575):634-636.
15. Olivera A, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity. 2007;26(3):287-297. (Pubitemid 46413904)
16. Jolly PS, et al. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med. 2004;199(7):959-970.
17. Price MM, Kapitonov D, Allegood J, Milstien S, Oskeritzian CA, Spiegel S. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEB J. 2009;23(10):3506-3515.
18. Igarashi J, Michel T. Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res. 2009; 82(2):212-220.
19. Means CK, Brown JH. Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res. 2009; 82(2):193-200.
20. Lee JF, et al. Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature. Am J Physiol Heart Circ Physiol. 2009;296(1):H33-H42.
21. Makabe-Kobayashi Y, et al. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol. 2002;110(2):298-303.
22. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150.
23. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009;64(2):204-212.
24. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest. 1997;99(5):901-914. (Pubitemid 27123627)
25. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP. Absence of FcεRI α chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis - Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chains. J Clin Invest. 1997; 99(5):915-925. (Pubitemid 27123628)
26. Roberts F, Calcutt CR. Histamine and the hypothalamus. Neuroscience. 1983;9(4):721-739.
27. Allende ML, et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem. 2004;279(50):52487-52492.
28. Venkataraman K, et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res. 2008;102(6):669-676. (Pubitemid 351457860)
29. Huwiler A, et al. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-α- dependent mechanism. Biochim Biophys Acta. 2006; 1761(3):367-376.
30. Chrusch C, et al. Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis. Am J Respir Crit Care Med. 1999;160(4):1142- 1149.
31. Felix SB, et al. Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis. Agents Actions. 1991; 33(3-4):349-358.
32. Forrest M, et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther. 2004;309(2):758-768. (Pubitemid 38542632)
33. Skoura A, Hla T. Regulation of vascular physiology and pathology by the S1P2 receptor subtype. Cardiovasc Res. 2009;82(2):221-228.
34. Allende ML, et al. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J. 2008;22(1):307-315.
35. Halpern BN, Neveu T, Wilson CW. The distribution and fate of radioactive histamine in the rat. J Physiol. 1959;147:437-449.
36. Sedor JR, Abboud HE. Actions and metabolism of histamine in glomeruli and tubules of the human kidney. Kidney Int. 1984;26(2):144-152.
37. Abboud HE. Catabolism of histamine in the isolated glomeruli and tubules of the rat kidney. Kidney Int. 1983;24(4):534-541.
38. Urtz N, et al. Early activation of sphingosine kinase in mast cells and recruitment to FcεRI are mediated by its interaction with Lyn kinase. Mol Cell Biol. 2004;24(19):8765-8777. (Pubitemid 39245094)
39. Lieberman P, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97(5):596-602. (Pubitemid 44851454)
40. Morrow JD, Margolies GR, Rowland J, Roberts LJ 2nd. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med. 1991; 324(11):716-720.
41. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185-1196.
42. Hershko AY, Dranitzki Z, Ulmanski R, Levi-Schaffer F, Naparstek Y. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis. Scand J Clin Lab Invest. 2001;61(6):449-452. (Pubitemid 32900432)
43. MacGlashan D Jr. Histamine: a mediator of inf lammation. J Allergy Clin Immunol. 2003; 112(4 Suppl):S53-S59.
44. Akdis CA, Jutel M, Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem Immunol Allergy. 2008;94:67-82.
45. Toubanaki DK, Christopoulos TK, Ioannou PC, Flordellis CS. High-throughput chemiluminomet ric genotyping of single nucleotide polymorphisms of histamine, serotonin, and adrenergic receptor genes. Anal Biochem. 2009;385(1):34-41.
46. Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol. 2009;157(1):24-33.
47. Dvorak AM. Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle. Chem Immunol Allergy. 2005;85:185-204.
48. Leach L, Eaton BM, Westcott ED, Firth JA. Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res. 1995;50(3):323-337.
49. Bolz SS, et al. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation. 2003; 108(3):342-347.
50. Keller M, et al. Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J. 2006;20(6):702-704. (Pubitemid 46671187)
51. Peter BF, et al. Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res. 2008;103(3):315-324.
52. Kono M, et al. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem. 2004; 279(28):29367-29373.
53. Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 2005; 19(12):1646-1656.
54. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ. Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R440-R446. (Pubitemid 46089859)
55. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol. 2007;27(6):1312-1318. (Pubitemid 46809419)
56. Ohmori T, et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res. 2003;58(1):170-177. (Pubitemid 36351635)
57. Davis MD, Clemens JJ, Macdonald TL, Lynch KR. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem. 2005;280(11):9833-9841.
58. Tauseef M, et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res. 2008;103(10):1164-1172.
59. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol. 2005;25(24):11113-11121. (Pubitemid 41747151)
60. Kono M, et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem. 2007; 282(14):10690-10696. (Pubitemid 47093459)
61. Qi Z, et al. Serial determination of glomerular filtration rate in conscious mice using FITCinulin clearance. Am J Physiol Renal Physiol. 2004; 286(3):F590-F596. (Pubitemid 38233654)